Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer

Abstract Background Liquid biopsy has been widely researched for early diagnosis, prognostication and disease monitoring in lung cancer, but there is a need to investigate its clinical utility for early-stage non-small cell lung cancer (NSCLC). Methods We performed a meta-analysis and systematic rev...

Full description

Bibliographic Details
Main Authors: Haifeng Shen, Yichen Jin, Heng Zhao, Manqi Wu, Kai Zhang, Zihan Wei, Xin Wang, Ziyang Wang, Yun Li, Fan Yang, Jun Wang, Kezhong Chen
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Medicine
Subjects:
Early-stage NSCLC
Liquid biopsy
Diagnostic accuracy
Prognostic values
Molecular residual disease
Predictive values
Online Access:https://doi.org/10.1186/s12916-022-02681-x

Internet

https://doi.org/10.1186/s12916-022-02681-x

Similar Items